GoodRx Appoints Jody Mulkey As Chief Technology Officer

GoodRx has announced the appointment of Jody Mulkey as Chief Technology Officer.

Mulkey is a seasoned technology executive with over 20 years of experience leading technology teams at Aspiration, Shopzilla and Ticketmaster. As CTO, Mulkey will oversee GoodRx’s engineering, data and technical product management teams.

“As we continue to develop new ways to help Americans afford and understand their healthcare, our platform must be able to keep pace with our continued rate of innovation,” said GoodRx co-CEO and co-founder Doug Hirsch. “Jody’s experience scaling technology platforms for consumer marketplaces will allow us to quickly amplify growth and further our mission of reducing healthcare costs for all Americans.”

An accomplished technology leader, Mulkey is known for building high-performance systems and teams. Most recently, Mulkey was Chief Product Officer at online financial firm Aspiration, which doubled its customer base and quadrupled in revenue during his tenure. Mulkey also spent five years as CTO of Ticketmaster, where he led its technology and cultural transformation. Prior to Ticketmaster, Mulkey spent 14 years at online marketplace Shopzilla, now Connexity, which has a global audience of more than 40 million shoppers monthly.

“I feel fortunate to join a company with such a compelling mission and look forward to helping build out GoodRx’s technology platform as the company continues its trajectory of hyper-growth,” said Mulkey. “With millions of Americans struggling to afford rising healthcare costs, GoodRx is in a unique position to not only help consumers save money but also to empower them to make informed decisions about their healthcare.”

Mulkey’s appointment comes as GoodRx works to support significant business growth as it expands its offerings and services. The company recently launched GoodRx Care, an online medical service that connects patients to physicians. This November, GoodRx announced it has provided Americans with more than $15 billion in healthcare savings since its founding and now helps save Americans more than $20 million every day through its mobile apps, website, and discount cards.


Humana to Acquire Enclara Healthcare

Humana Inc. has announced it has signed a definitive agreement to acquire privately held Enclara Healthcare (Enclara), one of the nation’s largest hospice pharmacy and benefit management providers, from Consonance Capital Partners and Enclara management. Enclara is a leading pharmacy solutions provider focused on simplifying care delivery in complex care populations to improve patient experience, quality and cost.

The Enclara acquisition provides Humana with the opportunity to extend its comprehensive care continuum strategy to cover the pharmacy-related needs associated with hospice care, simplify the mail order pharmacy experience, and advance its technology stack for in-home pharmacy through areas such as enhanced mobile medication management and improved electronic medical record (EMR) connectivity.

“Enclara represents a logical extension of Humana Pharmacy’s strategy given the company’s unique ability to play a role in advanced illness care and supplement our existing care delivery system,” said Scott Greenwell, PharmD, President, Humana Pharmacy Solutions. “We look forward to leveraging and expanding the capabilities of Enclara to further advance our clinical management expertise.”

Enclara has cultivated trusted relationships with its customers, serving over 450 hospice providers and 97,000 hospice patients per day through multiple, scalable models designed to fit unique customer needs.

“I am excited about the opportunity to work closely with Humana to carry on Enclara’s mission of serving as an invaluable resource to hospice providers,” said Andrew Horowitz, Founder and Chief Executive Officer, Enclara Healthcare. “This combination will allow Enclara to accelerate innovation aimed at delivering timely and cost effective pharmacy solutions.”

The Enclara transaction, which includes acquisition of Enclara Pharmacia, GuidantRx and Avanti Health Care Services, is anticipated to close during the first half of 2020 and is subject to customary state and federal regulatory approvals as well as other customary closing conditions. Financial terms of the transaction were not disclosed. The transaction is expected to have an immaterial impact to earnings in 2020.

Centerview Partners LLC is acting as financial advisor to Humana. Crowell & Moring LLP is acting as legal advisor to Humana. Evercore Inc. is acting as financial advisor to Enclara and Consonance Capital Partners. Latham & Watkins LLP is acting as legal advisor to Enclara and Consonance Capital Partners.

Subscribe to this RSS feed